ImClone Investigational Site — Buffalo, New York

ImClone Investigational Site is a clinical research site located in Buffalo, New York, United States 14263.

Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

ImClone Investigational Site has participated in 4 clinical trials.

Therapeutic areas: Metastatic Malignant Melanoma, Metastatic Renal Cell Carcinoma, Colorectal Cancer.

Sponsors: Eli Lilly and Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Buffalo

Browse all research sites in New York · View every site in Buffalo

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for ImClone Investigational Site?

ImClone Investigational Site has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has ImClone Investigational Site conducted?

ImClone Investigational Site has 4 clinical trials on record. Their work covers Metastatic Malignant Melanoma, Metastatic Renal Cell Carcinoma, Colorectal Cancer.

Is ImClone Investigational Site accredited by Crixeo Clinical Trials?

ImClone Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about ImClone Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.